- Bristol Myers Squibb (Princeton, NJ)
- …(internal & external). This position plays a critical role in ensuring the clinical differentiation of BMS' HO Early Assets across the HO portfolio. Development ... strategy for: 1) set of assets within our Oncology early development portfolio & 2) input to translational medicine...and execution of medical differentiation plans is executed across 4 domains: 1) Insight… more
- Otsuka America Pharmaceutical Inc. (Princeton, NJ)
- …communication of insights across preclinical, early and late-stage assets. The Senior Director , Translational Research and Biomarkers will liaise with the ... **Job Summary** The Senior Director , Translational Research and Biomarkers...and manages development and clinical integration of biomarkers for early and late-stage assets. The role oversees a team… more
- Otsuka America Pharmaceutical Inc. (Trenton, NJ)
- **Position Summary:** The Executive Director , Global Value Evidence Lead, is a strategic leader responsible for driving the global value evidence strategy across the ... company's portfolio. This senior leader will provide strategic vision and leadership for...innovative, and fit-for-purpose evidence is generated to support product differentiation , market access, and reimbursement across geographies. The incumbent… more
- Bristol Myers Squibb (Princeton, NJ)
- …development and enable continuous improvements without compromising quality. + Engages senior leaders and functional area stakeholders to ensure alignment of program ... commercial strategy. + Understands and reflects the impact of VAP inputs ( Early Access Review and DEX recommendations, commercial opportunity assessment, TOP / TPP… more
- Otsuka America Pharmaceutical Inc. (Princeton, NJ)
- …for Company Core Data Sheet (CCDS), USPI and local labeling from early -stage development through to product maintenance. Facilitate strategic development of labeling ... manner. + Ability to understand and address payer needs and commercial differentiation strategies. + During HA reviews, continuously assess dossier review comments… more